Related references
Note: Only part of the references are listed.EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Gyorgy Nagy et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
Saedis Saevarsdottir et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search
Nadia M. T. Roodenrijs et al.
RHEUMATOLOGY (2022)
DRUG RETENTION OF BIOLOGICS OR JAK INHIBITORS IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: RESULTS FROM THE ANSWER COHORT
R. Watanabe et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Yasmin Khader et al.
CLINICAL RHEUMATOLOGY (2022)
Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid Arthritis
Takeshi Iwasaki et al.
FRONTIERS IN IMMUNOLOGY (2022)
'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps
Yvonne Tan et al.
RMD OPEN (2022)
Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis
Ichiro Yoshii et al.
RHEUMATOLOGY INTERNATIONAL (2022)
Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort
Ryu Watanabe et al.
IMMUNOLOGICAL MEDICINE (2022)
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Sae Ochi et al.
ARTHRITIS RESEARCH & THERAPY (2022)
EULAR definition of difficult-to-treat rheumatoid arthritis
Gyorgy Nagy et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015
Bryant R. England et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
Markus Rehberg et al.
RHEUMATOLOGY AND THERAPY (2021)
Multiomics and Machine Learning Accurately Predict Clinical Response to Adalimumab and Etanercept Therapy in Patients With Rheumatoid Arthritis
Weiyang Tao et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis
Maya H. Buch et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease
Nadia M. T. Roodenrijs et al.
RHEUMATOLOGY (2021)
Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice
Satoshi Takanashi et al.
RHEUMATOLOGY (2021)
Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study
Nadia M. T. Roodenrijs et al.
RHEUMATOLOGY (2021)
Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon
Marianne A. Messelink et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
Nadia M. T. Roodenrijs et al.
RMD OPEN (2021)
Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
Nadia M. T. Roodenrijs et al.
RMD OPEN (2021)
Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network
Elena Nikiphorou et al.
RHEUMATOLOGY (2020)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
Marta Novella-Navarro et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Risk profiling for a refractory course of rheumatoid arthritis
Manuel Becede et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Difficult-to-treat rheumatoid arthritis: an area of unmet clinical need
Maria J. H. de Hair et al.
RHEUMATOLOGY (2018)
Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Lianne Kearsley-Fleet et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Rheumatoid arthritis
Josef S. Smolen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey
Nadia M. T. Roodenrijs et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)